|
| PLC Life Sciences multi-jursidictional guide: Editorial Board | Editorial board |
|
| Life Sciences: Super Leagues 2012 This article reveals the results of the 2012 Life Sciences Industry and Regulatory Super Leagues. The Super Leagues encompass the best firms according to our research, which have the highest number of recommendations for their practices and lawyers in industry and regulatory work, and which are spread over at least two continents (see box, Methodology). The tables are based on the most recent rankings by PLC Which lawyer? for Life Sciences which can be found here, and is correct as of 29th February 2012. | Special features |
|
| Life Sciences: Argentina A Q&A guide to life sciences law in Argentina. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Argentina, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Australia A Q&A guide to life sciences in Australia. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Australia, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Austria A Q&A guide to life sciences law in Austria. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Austria, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Belgium A Q&A guide to life sciences law in Belgium. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Belgium, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Brazil A Q&A guide to life sciences law in Brazil. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Brazil, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Canada A Q&A guide to life sciences law in Canada. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Canada, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: China A Q&A guide to life sciences in China. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in China, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Denmark A Q&A guide to life sciences law in Denmark. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Denmark, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Finland A Q&A guide to life sciences law in Finland. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Finland, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: France A Q&A guide to life sciences law in France. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in France, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Germany A Q&A guide to life sciences law in Germany. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Germany, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to Life Sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifescienceshandbook. | Country Q&A |
| Life Sciences: Greece A Q&A guide to life sciences law in Greece. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: India A Q&A guide to life sciences law in India. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in India, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Ireland A Q&A guide to life sciences law in Ireland. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Ireland, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Italy A Q&A guide to life sciences law in Italy. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Italy, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Japan A Q&A guide to life sciences law in Japan. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Japan, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Mexico A Q&A guide to life sciences in Mexico. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Mexico, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Norway A Q&A guide to life sciences in Norway. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Norway, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Poland A Q&A guide to life sciences law in Poland. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Poland, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to Life Sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Russian Federation A Q&A guide to life sciences law in the Russian Federation. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in the Russian Federation, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: South Africa A Q&A guide to life sciences law in South Africa. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in South Africa, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: South Korea A Q&A guide to life sciences in South Korea. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Spain A Q&A guide to life sciences law in Spain. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Spain, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Sweden A Q&A guide to life sciences law in Sweden. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Sweden, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Switzerland A Q&A guide to life sciences law in Switzerland. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in Switzerland, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to Life Sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Thailand A Q&A guide to life sciences law in Thailand. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in Thailand, please visit PLC Which lawyer? This Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: The Netherlands A Q&A guide to life sciences in The Netherlands. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in The Netherlands, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: UK (England and Wales) A Q&A guide to life sciences in the UK (England and Wales). The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences law firms and lawyers in England, please visit PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Ukraine A Q&A guide to life sciences law in the Ukraine. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in the Ukraine, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: United States A Q&A guide to life sciences law in the United States. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. For a full list of recommended life sciences lawyers and law firms in the United States, see PLC Which lawyer? To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. The Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
| Life Sciences: Vietnam A Q&A guide to life sciences law in Vietnam. The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. To compare answers across multiple jurisdictions, visit the Life Sciences Country Q&A tool. This Q&A is part of the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Country Q&A |
|
| Data protection and life sciences: impact of the proposed EU regulation This article sets out the background to the European Commission's proposed new regulation to protect individuals relating to the processing of personal data and the free movement of such data, in relation to clinical trials (including data controllers and data processors and international transfers of clinical data), pharmacovigilance, health data and consent and medical research. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| EU and US regulation of health information technology, software and mobile apps The emergence of integrated health information systems, mobile apps and software-based medical devices presents significant opportunities in managing healthcare costs and achieving better outcomes. This article analyses the developing EU and US approaches to health information technology (health IT) and mobile medical applications (MMAs), and the emerging rules and compliance issues for companies developing and marketing these products. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Generics and biosimilars in Brazil: elements of the industrial policy of the Brazilian government This chapter provides an overview of the challenges facing the pharmaceutical industry in Brazil, including the regulatory framework for generics, similars and biosimilars, the exponential growth of the market, the problems still existing in the competition with non-interchangeable copies (similars) and the absence of compliance with international standards, to date. The Brazilian government policies to favour domestic pharmaceutical industries and the country's lack of clear rules regarding the purchasing preferences, with its recently enacted government purchasing programme, are also covered. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Impact of the South Korea-US Free Trade Agreement on the Korean pharmaceutical industry This chapter analyses the provisions of the South Korea-US Free Trade Agreement (FTA), which was signed by South Korea and the US on 30 June 2007 and will take effect on 15 March 2012. It looks at the FTA in terms of the adoption of the independent review process in the pharmaceutical sector, the introduction of the approval-patent linkage system, data exclusivity, customs duties and non-tariff barriers and competition law. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Key considerations for European M&A in the life sciences sector This article illustrates how a complex and evolving legal and regulatory environment gives rise to unique challenges for those engaged in European M&A in the life sciences sector, by analysing a hypothetical M&A. In particular, it examines: • A life sciences M&A case study. • Due diligence and its impact. • Intellectual property issues. • Structuring the deal. • European competition laws. • Anti-corruption laws. • Employment issues. • Tax issues. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Out of bounds: CMS proposed rule for AMP under Medicaid This article explores some of the problematic aspects of CMS' proposals to regulate the MDRP, including its questionable exercise of delegated authority. In particular, it examines historical regulation of AMP, expansion of the Medicaid drug rebate programme, determining indirect sales to retail community pharmacies, calculating AMP for 5i drugs, Best Price, new requirements for line extensions, treatment of coupons, vouchers and co-payment assistance, new definition of wholesaler and the authorised generic rule on AMP and changes to CMS' policy on restatements of AMP and Best Price. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Parallel trade and pharmaceuticals in the EU: current issues Parallel trade in the European pharmaceutical sector is widespread. To deal with parallel trade, pharmaceutical companies operating in the EU usually respond by adopting dual pricing schemes and allocation systems. To a certain extent, such schemes and systems are supported by European pharmaceuticals regulation. Behaviour such as dual pricing schemes and supply allocation systems have been the subject of legal dispute for some years. Another issue that continues to be the subject of legal dispute concerns the repackaging of pharmaceuticals that have been parallel imported. This chapter considers recent case law on these issues and summarises any conclusions that can be drawn. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Patent settlement agreements: the state of play in the EU and the US This chapter describes the extent of anti-trust enforcement in the context of patent settlement agreements in the EU and US, sets out the current positions of the anti-trust authorities and any legislative initiatives taken in this area, and documents significant pending competition investigations or litigation in the EU and US. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Patents in Ukraine: where are we now? This article looks at patent regulation in Ukraine, focusing on: The regulatory framework. Patent protection and enforcement. Enforcement and defence of patent rights in Ukrainian courts. Patent infringement on the internet. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Recent case law and current issues relating to Supplementary Protection Certificates This article includes: A general overview of SPCs. A summary of key recent case law from the EU Court of Justice (ECJ) on the conditions for obtaining an SPC. Negative term SPCs and paediatric extensions. An analysis of marketing authorisation in the context of SPCs. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Reform of litigation funding and implications for life sciences companies Various reforms have been proposed to the litigation funding regime in England and Wales. This article examines the nature of the reforms and other proposals, conditional fee agreements, after the event insurance, damages based agreements, third party funding/litigation funding, qualified one-way cost shifting, liberalisation of the legal market and the impact on pharmaceutical claims. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| Regulatory data protection in the EU: an update Under European pharmaceutical law innovator pharmaceutical companies are granted a period of regulatory data exclusivity in which a generic applicant cannot refer to the innovator's data to obtain a marketing authorisation. The European legislation was amended in 2004 and currently contains a period of eight plus two (plus one) years of regulatory data protection (RDP). This article sets out a brief description of RDP under European law, the main changes to the legal system introduced in 2004 and an update of recent developments regarding the interpretation of European RDP law. This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
| The 2012 Biotechnology Public Policy and Litigation Agenda in Canada This chapter looks at recent developments in Canadian public policy and case law that directly or indirectly affect biotechnology. It summarises the 2009 Canadian federal budget and a number of recommendations for improving government programmes, including the 2010 report, "An Action Plan For Prosperity", published by the Coalition for Action on Innovation in Canada. It then outlines the key issues and challenges for the Canadian government to improve business R&D spending, rates of commercialisation and productivity growth. Finally, this chapter looks at the functions of the Patented Medicine Prices Review Board (PMPRB) and recent litigation trends (including class actions). This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Cross-border chapters |
|
| Summary of patent protection The table summarises patent protection in the jurisdictions covered in the PLC multi-jurisdictional guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg. | Feature tables |
|
| Life Sciences: PLC Which lawyer? This section is designed to assist lawyers and clients in identifying life sciences counsel in 35 jurisdictions. Our editorial team has researched the legal markets worldwide to identify the firms and individuals that the market considers to have expertise in this practice area. Firms are listed by jurisdiction and ranked as follows: Leading Highly Recommended Recommended Recognised Individuals are listed by jurisdiction and alphabetically by surname. For more information on how PLC Which lawyer? rankings are compiled please click here. The PLC Which lawyer? section should be read in conjunction with the Lawyer profiles section which contains more detailed biographies of some individuals. Follow the links for recommended counsel in the life sciences law sectors. This research is part of the PLC multi-jurisdictional guide to Life Sciences law and leading practitioners worldwide. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg | PLC Which lawyer? |
|
| Baechtold, Robert L (USA: NY: New York) | Lawyer profiles |
| Band, Tal (Israel) | Lawyer profiles |
| Bareket, Eran (Israel) | Lawyer profiles |
| Bass, Scott (USA: DC: Washington) | Lawyer profiles |
| Beck, Thomas H (USA: NY: New York) | Lawyer profiles |
| Bonner, Raymond A (USA: DC: Washington) | Lawyer profiles |
| Cannella, Nicholas (USA: NY: New York) | Lawyer profiles |
| Conde, Dominick (USA: NY: New York) | Lawyer profiles |
| Cuonzo, Gabriel (Italy) | Lawyer profiles |
| Davis, Michael W (USA: IL: Chicago) | Lawyer profiles |
| Dettling, Heinz-Uwe (Germany) | Lawyer profiles |
| Ducor, Philippe (Switzerland) | Lawyer profiles |
| Ebbink, Richard (The Netherlands) | Lawyer profiles |
| Eggenberger Stöckli, Ursula (Switzerland) | Lawyer profiles |
| Eklund (formerly Legnerfält), Elisabeth (Sweden) | Lawyer profiles |
| Engin-Deniz, Egon (Austria) | Lawyer profiles |
| Farrington, James F (USA) | Lawyer profiles |
| Fréget, Olivier (France) | Lawyer profiles |
| Geneste, Bernard (France) | Lawyer profiles |
| Gilbert, Penny (England) | Lawyer profiles |
| Gourley, Sara J (USA: IL: Chicago) | Lawyer profiles |
| Graham, Stephen M (USA: WA: Seattle) | Lawyer profiles |
| Grosperrin, Jean-Marc (France) | Lawyer profiles |
| Gutmans, Alexander (Switzerland) | Lawyer profiles |
| Hellbert, Karina (Austria) | Lawyer profiles |
| Jha, Pran (USA: IL: Chicago) | Lawyer profiles |
| Kalb, MD, Paul E (USA: DC: Washington) | Lawyer profiles |
| Klasmeier, Coleen (USA: DC: Washington) | Lawyer profiles |
| Kletzer, Constantin (Austria) | Lawyer profiles |
| Kochanski, Piotr (Poland) | Lawyer profiles |
| Krogsrud, Børge (Norway) | Lawyer profiles |
| Kushan, Jeffrey P (USA: DC: Washington) | Lawyer profiles |
| L'Ecluse, Peter (Belgium) | Lawyer profiles |
| Licks, Otto (Brazil) | Lawyer profiles |
| Longeval, Catherine (Belgium) | Lawyer profiles |
| Lugard, Maurits (European Union) | Lawyer profiles |
| Mahinka, Stephen Paul (USA: DC: Washington) | Lawyer profiles |
| Mandra, Raymond (USA: NY: New York) | Lawyer profiles |
| Melandsø, Nina (Norway) | Lawyer profiles |
| Meulenbelt, Maarten (Belgium and The Netherlands and European Union) | Lawyer profiles |
| Mondini, Andrea (Switzerland) | Lawyer profiles |
| Monteiro, César Bessa (Portugal) | Lawyer profiles |
| Nagy-Koppany, Kornelia (Hungary) | Lawyer profiles |
| Nogueira Pinto, Eduardo (Portugal) | Lawyer profiles |
| Nordlander, Kristina (European Union) | Lawyer profiles |
| Ørndrup, Jacob (Denmark) | Lawyer profiles |
| Osterrieth, Christian (Germany) | Lawyer profiles |
| Pasahow, Lynn H (USA: CA: San Francisco and Silicon Valley) | Lawyer profiles |
| Polak, Peter (Austria) | Lawyer profiles |
| Pole, Debra E (USA: CA: Los Angeles) | Lawyer profiles |
| Powell, Tim (England) | Lawyer profiles |
| Pritikin, David T (USA: IL: Chicago) | Lawyer profiles |
| Reimann, Thomas W (Germany) | Lawyer profiles |
| Robert, Jacques-Antoine (France) | Lawyer profiles |
| Sanzo, Kathleen M (USA: DC: Washington) | Lawyer profiles |
| Scherrer, Dr Frank (Switzerland) | Lawyer profiles |
| Scherrer, Dr Josef (Switzerland) | Lawyer profiles |
| Selletti, Sonia (Italy) | Lawyer profiles |
| Silvis, Lauren (USA: DC: Washington) | Lawyer profiles |
| Stansel, James (USA: DC: Washington) | Lawyer profiles |
| Sunberg, Randall (USA) | Lawyer profiles |
| Thayer, Patricia (USA: CA: San Francisco and Silicon Valley) | Lawyer profiles |
| Treece, John (USA: IL: Chicago) | Lawyer profiles |
| Turnill, Amanda (Australia) | Lawyer profiles |
| Utterstrom, Peter (Sweden) | Lawyer profiles |
| van Gardingen, Mark (The Netherlands) | Lawyer profiles |
| Versteeg, Arnold (The Netherlands) | Lawyer profiles |
| Vignaud, François (France) | Lawyer profiles |
| von Czettritz, Peter (Germany) | Lawyer profiles |
| Warnock-Smith, Anthony (England) | Lawyer profiles |
| Wilow, Staffan (Sweden) | Lawyer profiles |
| Yang, Chen (China) | Lawyer profiles |
| Zegger, Paul J (USA: DC: Washington) | Lawyer profiles |